Bessemer Group’s Genetic Technologies Ltd. GENE Stock Holding History

Bessemer Group’s Portfolio GENE Stock Details GENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-24	Closed	–	–	2759
2025 Q3	$0	Buy	+24	New	–	﹤0.01%	2770

Other funds holding GENE

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Bessemer Group's GENE Position: Q4 2025 in Review

Bessemer Group sold out of Genetic Technologies Ltd. (GENE) in Q4 2025, closing a stake of 24 shares.

Bessemer Group first reported a position in GENE in Q3 2025 and held it in 1 quarter. The position peaked at $0 in Q3 2025. 2 funds tracked by Wall St. Rank hold GENE as of Q4 2025.

Bessemer Group reported no remaining Genetic Technologies Ltd. position as of Q4 2025 after selling out during the quarter.
Bessemer Group sold 24 Genetic Technologies Ltd. shares in Q4 2025.
Bessemer Group first reported a position in Genetic Technologies Ltd. in Q3 2025 and held it in 1 quarter.
Bessemer Group's Genetic Technologies Ltd. position peaked at $0 in Q3 2025.
2 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q4 2025.

Based on Bessemer Group's 13F filing for Q4 2025, filed 5 Feb 2026.